[1] Bartucci M,M orelli C,Mauro L,et al.Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.Cancer Res,2001,61(18):6747-6754.
[2] Macaulay VM,Salisbury A J,Bohula EA,et al.Downregulation of the type 1 insulin-like growth factor receptor in mouse melanoma cells is associated with enhanced radiosensitivity and impaired activation of Atm kinase.Oncogene,2001,20(30):4029-4040.
[3] Peretz S,Jensen R,Baserga R,et al.ATM-dependent expression of the insulin-like growth factor-1 receptor in a pathway regulating radiation response.PNAS,2001,98(4):1676-1681.
[4] Soderlund K,Perez-Tenorio G,Stal O.Activation of the phosphatidylinositol 3-kinase/Akt pathway prevents radiation-induced apoptosis in breast cancer cells.Int J Oncol,2005,26(1):25-32.
[5] Sartor CI.Epidermal growth factor family receptors and inhibitors:radiation response modulators.Semin Radiat Oncol,2003,13(1):22-30.
[6] Zhou H,Kim YS,Peletier A,et al.Effects of the EGFR/HER2 kinase inhibitor GW572016 on EGFR- and HER2-overexpressing breast cancer cell line proliferation,radiosensitization,and resistance.Int J Radiat Oncol Biol Phys,2004,58(2):344-352.
[7] Liang K,Lu Y,Jin W,et al.Sensitization of breast cancer cells to radiation by trastuzumab.Mol Cancer Ther,2003,2(11):1113-1120.
[8] Gupta VK,Jaskowiak NT,Beckett MA,et al.Vascular endothelial growth factor enhances endothelial cell survival and tumour radioresistance.Cancer,2002,8(1):47-54.
[9] Wachsberger P,Burd R,Dicker AP.Tumour response to ionizing radiation combined with antiangiogenesis or vascular targeting agents:exploring mechanisms of interaction.Clin Cancer Res,2003,9(6):1957-1971.
[10] Marchetti P,Cannita K,Ricevuto E,et al.Prognostic value of p53 molecular status in high-risk primary breast cancer.Ann Oncol,2003,14(5):704-708.
[11] Wachsberger P,Burd R,Dicker AP.Improving tumor response to radiotherapy by targeting angiogenesis signaling pathways.Hematol Oncol Clin North Am,2004,18(5):1039-1057.
[12] Couture C,Raybaud-Diogene H,Tetu B,et al.p53 and Ki-67 as markers of radioresistance in head and neck carcinoma.Cancer,2002,94(3):713-722.
[13] Enns L,Bogen KT,Wizniak J,et al.Low-dose radiation hypersensitivity is associated with p53-dependent apoptosis.Mol Cancer Res,2004,2(10):557-566.
[14] Powell SN,Kachnic LA.Roles of BRCA1 and BRCA2 in homologous recombination,DNA replication fidelity and the cellular response to ionizing radiation.Oncogene,2003,22(37):5784-5791.
[15] Xia F,Taghian DG,DeFrank JS,et al.Deficiency of human BRCA2 leads to impaired homologous recombination but maintains normal nonhomologous end joining.Proc Natl Acad Sci USA,2001,98(15):8644-8649.
[16] Lear-Kaul KC,Yoon HR,Kleinschmidt-DeMasters BK,et al.Her2/neu status in breast cancer metastases to the central nervous system.Arch Pathol Lab Med,2003,127(11):1451-1457.
[17] Slijepoevic P.Is there a link between telomere maintenance and radiosensitivity?.Radiat Res,2004,161(1):82-86.
[18] Provenzano E,Hopper JL,Giles GG,et al.Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast.Eur J Cancer,2003,39(5):622-630.
[19] Van't Veer LJ,Dai H,van de Vijver MJ,et al.Gene expression profiling predicts clinical outcome of breast cancer.Nature,2002,415(6871):530-536.
[20] Van de Vijver MJ,He YD,van't Veer LJ,et al.A geneexpression signature as a predictor of survival in breast cancer.N Engl J Med,2002,347(25):1999-2009.